So what’s wrong with Biotech financing today? What will it take to bring the Biotech market out of the doldrums and back into action? If you are having trouble finding financing for your next greatest idea then the only comforting news is that you are not alone....
Blog Series: 1 of 4 When it comes to venture capital and growth equity investments, the bottom line is the top line. If a company can grow its revenue, then odds are it will generate a strong return for its investors. Market due diligence is a key component of...
Blog Series 2 of 4 The Standard Market Due Diligence Process The typical market due diligence effort generally includes three components. To help explain each component and how they fit into the overall market assessment, we’ll illustrate this section using an...
Blog Series 3 of 4 Pipeline Interviews: The Missing Piece At this point, you may be thinking, “The analysis addressed the overall market size, the potential penetration of the market, and the company’s likely share. Shouldn’t that be enough?”...
Blog series 4 of 4 Conducting Pipeline Interviews There are two keys to conducting Pipeline Interviews. First, make sure to interview accounts at a variety of stages in the pipeline. The reasons why prospects don’t progress past the first meeting usually concern the...
Blog 3 of 3 in the Due Diligence Often Discovers Discrepancies series I expect that there are many folks out there who will challenge our analysis. I’ve anticipated some of the objections and have addressed what I think are the three major ones below. 1....
